Log in to save to my catalogue

Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for hear...

Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for hear...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9987542

Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for heart failure patients

About this item

Full title

Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for heart failure patients

Publisher

Poland: Wydawnictwo Via Medica

Journal title

Cardiology journal, 2023-01, Vol.30 (1), p.143-149

Language

English

Formats

Publication information

Publisher

Poland: Wydawnictwo Via Medica

More information

Scope and Contents

Contents

Several mechanisms have been suggested to explain positive cardiovascular effects observed in studies with sodium-glucose co-transporter 2 (SGLT2) inhibitors. The reduction in glucose reabsorption in proximal tubuli induced by SGLT2 inhibitors increases urinary glucose and sodium excretion resulting in increased osmotic diuresis and consequently in...

Alternative Titles

Full title

Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for heart failure patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9987542

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9987542

Other Identifiers

ISSN

1897-5593

E-ISSN

1898-018X

DOI

10.5603/CJ.a2021.0133

How to access this item